BioSpace News Archive

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), today announced that that its President & Chief Executive Officer, Christopher U. Missling, PhD, will present a company update and participate in a panel at the 2020 BIO CEO & Investor Conference.

HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest independent health savings account (“HSA”) custodian, announced that it plans to release its fiscal year-end sales results following the close of regular stock market trading hours on Tuesday, February 18, 2020.

Encompass Health Corp., a national leader in integrated healthcare services, announced that it will host an investor day on March 4, 2020.

AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals and Trefoil Therapeutics announce the execution of a manufacturing contract to supply their lead compound TTHX1114.

SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, Chief Executive Officer, will present at the 2020 BIO CEO & Investor Conference on Tuesday, February 11 at 1:15 p.m. ET in New York.

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced the appointment of David Ailinger as Vice President, Business Development, reporting directly to Patrick J. McEnany, Catalyst’s Chairman and CEO.

Viralgen, a world-leading GMP manufacturer of AAV therapeutics, makes significant contribution in manufacturing capacity to serve children in need

CNS Pharmaceuticals, Inc. announced it has completed the final GMP manufacturing run of its lead candidate Berubicin, which it acquired from Reata Pharmaceuticals, Inc., and that the GMP material has met all specifications.

Heska Corporation, a provider of advanced veterinary diagnostic and specialty products, plans to report its fourth quarter and full year 2019 financial performance in a press release on Tuesday, February 25, 2020 before the market opens, and to host an earnings call to discuss the results following the release at 9 a.m. MT / 11 a.m. ET..

Epilepsy Foundation Florida announced that it has adopted the long-standing, successful nationwide Walk to END EPILEPSY® and bringing it to Miami on March 14, 2020 at Zoo Miami.